dihexa lipophilic Peptide Dihexa (50 mg) - Product

Figure 9 An automatically formatted report generated by Byos software showing a summary page with sequence coverage of wildtype and modified proteins, two peptide tables with all relevant information about each modified peptide, bar charts, and a plots tab including MS1, MS/MS, and XIC plots

While the therapeutic potential benefits of dihexa in Parkinsons disease is promising, it is important to note that further research is necessary to validate its efficacy and safety in human patients

Matsushima GK, Morell P

Many trials performed exploratory analyses of other potential biomarkers such as serum HGF level, tumour HGF level, MET gene copy number (amplification) and soluble MET concentrations (see Table 4)

We are currently in an internal evaluation phase, reviewing the published research and running a structured internal protocol with our clinical team

Light walking is fine